The eyelids have it: Diagnosing disease by examining blinking

The technology is relatively simple because it does not require a camera, image processing or storing data in a “cloud.”

October 15, 2017 18:23
2 minute read.
Adi Hanuka

Adi Hanuka. (photo credit: TECHNION)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


An innovative system for diagnosis of diseases based on eyelid movement was developed at the Viterbi Faculty of Electrical Engineering at Haifa’s Technion-Israel Institute of Technology.

In the past two years, the device has been used in clinical trials at the Emek Medical Center in Afula.

The first scientific publication for the Afapayim (Eyelids) project was recently presented in the journal Graefe’s Archive for Clinical and Experimental Ophthalmology of the Springer Group.

The unique project was developed by Prof. Levi Schechter and doctoral student Adi Hanuka, who began working on it for her bachelor’s degree. She then continued with the help of many student groups which worked under her supervision. It has already won several international awards and was ranked in the top 20 places in the Texas Instruments International Competition.

The technology is relatively simple because it does not require a camera, image processing or storing data in a “cloud.”

“Eyelid movements provide significant information about the patient’s health,” explained Hanuka, who is currently doing a doctorate in another field, under Schechter’s guidance, on particle accelerators for medical purposes, such as radiotherapy in the treatment of cancerous tumors. “These movements can point not only to eye diseases but also to neurological diseases, such as Parkinson’s disease and autoimmune diseases such as Graves’ disease [hyperthyroidism]. At the request of Dr. Daniel Brisko, chief of ophthalmology at Emek, we developed a device that is fitted with standard optometrist glasses used in eye examinations.”

The glasses are fitted with a system of hardware and software that monitors the user’s eyelid movements and decodes them. Since the approval of the Helsinki Committee for Human Experimentation, measurements of approximately 100 subjects have been collected to define the patterns of blinking (frequency and speed of closure) in a healthy person.

The analysis of the eyelid indices was carried out using a signal-processing algorithm written by four students in the faculty – Tal Berkowitz, Michal Spector, Shir Laufer and Naama Pearl.

The first disease to be diagnosed was blepharospasm dystonia, characterized by an involuntary contraction of the muscles responsible for closing the eyes. The researchers found a significant quantitative association between the person’s eyelid pattern and suffering from spasms of the eyelids.

The system also examined the effect of the usual treatment of the disease, Botox injection, and found that within 15 minutes of the injection, the contractions were alleviated and the eyelid movement pattern normalizes.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

A vial of measles, mumps and rubella vaccine and an information sheet.
May 16, 2019
Hundreds of haredim attend symposium with leaders of anti-vaccine movement